213 related articles for article (PubMed ID: 34216572)
81. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
[TBL] [Abstract][Full Text] [Related]
82. Impact of restarting warfarin therapy in renal disease anticoagulated patients with gastrointestinal hemorrhage.
Khalid F; Qureshi W; Qureshi S; Alirhayim Z; Garikapati K; Patsias I
Ren Fail; 2013 Oct; 35(9):1228-35. PubMed ID: 23902367
[TBL] [Abstract][Full Text] [Related]
83. Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease.
Potpara TS; Jokic V; Dagres N; Larsen TB; Lane DA; Hindricks G; Lip GY
Curr Med Chem; 2016; 23(19):2055-69. PubMed ID: 26861000
[TBL] [Abstract][Full Text] [Related]
84. Impact of Chronic Kidney Disease on the Presentation and Outcome of Patients Hospitalized With Atrial Fibrillation: Insights From Qatar.
Salim I; Al Suwaidi J; AlBinali HA; Singh R; Al-Qahtani A; Asaad N; Salam AM
Angiology; 2018 Mar; 69(3):212-219. PubMed ID: 28691505
[TBL] [Abstract][Full Text] [Related]
85. Impact of chronic kidney disease in patients undergoing percutaneous or surgical carotid artery revascularization: Insights of the healthcare cost and utilization Project's National Inpatient Sample.
Lima FV; Yen TY; Butler J; Yang J; Xu J; Gruberg L
Cardiovasc Revasc Med; 2016 Dec; 17(8):560-565. PubMed ID: 27988086
[TBL] [Abstract][Full Text] [Related]
86. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.
Nishimura M; Hsu JC
Am J Cardiol; 2018 Jan; 121(1):131-140. PubMed ID: 29132650
[TBL] [Abstract][Full Text] [Related]
87. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
[TBL] [Abstract][Full Text] [Related]
88. Intersection of cardiovascular disease and kidney disease: atrial fibrillation.
Bansal N; Hsu CY; Go AS
Curr Opin Nephrol Hypertens; 2014 May; 23(3):275-82. PubMed ID: 24709949
[TBL] [Abstract][Full Text] [Related]
89. Evaluation of warfarin dose requirements in patients with chronic kidney disease and end-stage renal disease.
Sakaan SA; Hudson JQ; Oliphant CS; Tolley EA; Cummings C; Alabdan NA; Self TH
Pharmacotherapy; 2014 Jul; 34(7):695-702. PubMed ID: 24851819
[TBL] [Abstract][Full Text] [Related]
90. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
[TBL] [Abstract][Full Text] [Related]
91. Appropriateness of prescription of oral anticoagulant therapy in acutely hospitalized older people with atrial fibrillation. Secondary analysis of the SIM-AF cluster randomized clinical trial.
Antoniazzi S; Ardoino I; Proietti M; Monzani V; Mannucci PM; Nobili A; Franchi C;
Br J Clin Pharmacol; 2019 Sep; 85(9):2134-2142. PubMed ID: 31218738
[TBL] [Abstract][Full Text] [Related]
92. Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials.
Proietti M; Lane DA; Lip GYH
EBioMedicine; 2016 Jun; 8():309-316. PubMed ID: 27428440
[TBL] [Abstract][Full Text] [Related]
93. Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study.
Minutolo R; Lapi F; Chiodini P; Simonetti M; Bianchini E; Pecchioli S; Cricelli I; Cricelli C; Piccinocchi G; Conte G; De Nicola L
Clin J Am Soc Nephrol; 2014 Sep; 9(9):1586-93. PubMed ID: 25074838
[TBL] [Abstract][Full Text] [Related]
94. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
[TBL] [Abstract][Full Text] [Related]
95. Clinical and Sociodemographic Predictors of Mortality in End-Stage Renal Disease Inpatients in Rural Areas of the USA: Evidence From the Nationwide Inpatient Sample.
Adeyemi E; Okpe A; Enete C; Dixon K
Cureus; 2022 Jun; 14(6):e25624. PubMed ID: 35784967
[TBL] [Abstract][Full Text] [Related]
96. Does Atrial Fibrillation Increase the Risk of Developing End-stage Renal Disease in Patients with Chronic Kidney Disease?
Suwanwongse K; Shabarek N
Cureus; 2020 Feb; 12(2):e6908. PubMed ID: 32190463
[TBL] [Abstract][Full Text] [Related]
97. Management and Outcomes of ST-Segment Elevation Myocardial Infarction in US Renal Transplant Recipients.
Gupta T; Kolte D; Khera S; Goel K; Aronow WS; Cooper HA; Jain D; Rihal CS; Fonarow GC; Panza JA; Bhatt DL
JAMA Cardiol; 2017 Mar; 2(3):250-258. PubMed ID: 28097322
[TBL] [Abstract][Full Text] [Related]
98. Specific Electrocardiograph Intervals Predict Hospitalization with Atrial Fibrillation in Those with Chronic Kidney Disease.
Scovner KM; Correa S; Claggett BL; Barrett CD; Waikar SS; Solomon SD; Mc Causland FR
Am J Nephrol; 2021; 52(5):412-419. PubMed ID: 33951623
[TBL] [Abstract][Full Text] [Related]
99. Impact of Chronic Kidney Disease on In-Hospital Outcomes of Hospitalizations With Acute Limb Ischemia Undergoing Endovascular Therapy.
Patel HP; Decter D; Thakkar S; Anantha-Narayanan M; Kumar A; Sheth AR; Zahid S; Patel BA; Patel T; Devani H; Shah V; Doshi PM; Patel S; Shariff M; Adalja D; Vallabhajosyula S; Doshi R
J Endovasc Ther; 2022 Nov; ():15266028221134887. PubMed ID: 36401519
[TBL] [Abstract][Full Text] [Related]
100. Indoxyl sulfate mediates low handgrip strength and is predictive of high hospitalization rates in patients with end-stage renal disease.
Hou YC; Liu YM; Liao MT; Zheng CM; Lu CL; Liu WC; Hung KC; Lin SM; Lu KC
Front Med (Lausanne); 2023; 10():1023383. PubMed ID: 36817773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
